Skip to main content
VCbacked
Log inGet Started

ImmuneSensor Therapeutics

Dallas, United States

ImmuneSensor Therapeutics is a biotechnology company that develops novel medicines for the treatment of cancer and other diseases.

$10.0M raised
Dec 2022
Series A
BiotechnologyHealth CareMedicalPharmaceutical

Top Investors

Cancer Prevention and Research Institute of Texas

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ImmuneSensor Therapeutics

How much funding has ImmuneSensor Therapeutics raised?
ImmuneSensor Therapeutics has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in December 2022.
Who are ImmuneSensor Therapeutics's investors?
ImmuneSensor Therapeutics's investors include Cancer Prevention and Research Institute of Texas.
Where is ImmuneSensor Therapeutics headquartered?
ImmuneSensor Therapeutics is headquartered in Dallas, United States.
What does ImmuneSensor Therapeutics do?
ImmuneSensor Therapeutics is a biotechnology company that develops novel medicines for the treatment of cancer and other diseases.
What stage is ImmuneSensor Therapeutics at?
ImmuneSensor Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"ImmuneSensor Therapeutics — Funding & Investors." VCBacked, December 5, 2022, https://www.vcbacked.co/company/immunesensor-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2022). ImmuneSensor Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/immunesensor-therapeutics
Wikipedia (cite web)
{{cite web |title=ImmuneSensor Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/immunesensor-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K